A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04096560 |
|
Recruitment Status :
Terminated
(A safety signal has emerged in Phase 2 studies of TAK-994. As an immediate precautionary measure, Takeda has suspended dosing of patients and has decided to stop Phase 2 studies early.)
First Posted : September 20, 2019
Last Update Posted : October 10, 2022
|
Sponsor:
Takeda
Information provided by (Responsible Party):
Takeda
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | November 5, 2021 |
| Actual Study Completion Date : | November 5, 2021 |
| Certification/Extension First Submitted : | October 5, 2022 |